TickerFacts.

Volitionrx Ltd (VNRX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.12M
As of 2025-12-31
$2.80M
As of 2026-06-30
-53.2%
3-year compound annual growth
-43.5%
5-year compound annual growth
-15.4%
10-year compound annual growth
$21.68M2011-12-31: $347.9K2012-12-31: $376.4K2015-12-31: $5.92M2016-12-31: $21.68M2017-12-31: $10.12M2018-12-31: $13.43M2019-12-31: $16.97M2020-12-31: $19.44M2021-12-31: $20.58M2022-12-31: $10.87M2023-12-31: $20.73M2024-12-31: $3.26M2025-12-31: $1.12M$1.12M
2011-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.12M-65.8%2026-03-31, Balance as of period end
2024-12-31$3.26M-84.3%2026-03-31, Balance as of period end
2023-12-31$20.73M+90.8%2025-03-31, Balance as of period end
2022-12-31$10.87M-47.2%2024-03-25, Balance as of period end
2021-12-31$20.58M+5.8%2023-03-15, Balance as of period end
2020-12-31$19.44M+14.6%2022-03-30, Balance as of period end
2019-12-31$16.97M+26.4%2021-03-22, Balance as of period end
2018-12-31$13.43M+32.7%2019-03-13, Balance as of period end
2017-12-31$10.12M-53.3%2019-03-13, Balance as of period end
2016-12-31$21.68M+266.4%2018-03-01, Balance as of period end
2015-12-31$5.92Mn/a2017-03-10, Balance as of period end
No annual figure between 2012-12-31 and 2015-12-31.
2012-12-31$376.4K+8.2%2013-04-01, Balance as of period end
2011-12-31$347.9Kn/a2013-04-01, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Volitionrx Ltd (VNRX)2025-12-31$1.12M-65.8%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$28.87M+1.8%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$11.58M+34.1%
Biomerica Inc (BMRA)2026-05-31$1.31M-45.5%
Anbio Biotechnology (NNNN)2025-12-31$7.77M-34.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$1.75M-0.8%
Immucell Corp (ICCC)2025-12-31$3.81M+1.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$5.91M+59.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$155.46M-17.8%

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗